No profile data available.
Ensysce Biosciences, Inc. (ENSC) is a healthcare company in the opioid pain relief pharmaceuticals industry, based in La Jolla, United States, with about 8 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$10.18 million. Its market capitalization was $10.25 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
Ensysce Biosciences reported $0 in revenue for fiscal year 2025.
$10.25 million as of October 9, 2026.
Listed companies of a similar size in the same industry (opioid pain relief pharmaceuticals) include Collegium Pharmaceutical, Inc. (COLL), Avenue Therapeutics, Inc. (ATXI), Trevena, Inc. (TRVN).